$362.1M in CY2024 Part D spend7.7M claims · 1.3M beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Divalproex used for?
Divalproex sodium extended-release tablets are indicated for: • Acute treatment of manic or mixed episodes associated with bipolar disorder, with or without psychotic features ( 1.1 ) • Monotherapy....
Is there a generic for Divalproex?
Yes. 56 ANDAs filed at FDA, 21 generic manufacturers currently shipping.
How much does my plan pay for Divalproex?
Across 329 Part D plans, Divalproex averages $0.065/unit (NADAC). Lowest available: $0.055/unit. Highest in distribution: $0.086/unit.
Is Divalproex on the FDA shortage list?
Divalproex has been discontinued by its manufacturer(s).
8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.